Investors have been pouring into rapidly developing AI tech names over the past few months, and this is likely just the beginning. According to Grand View Research, the global artificial intelligence market reached a valuation of $136.55 billion in 2022. It's projected that by 2030 the industry...
Regardless of what’s happening elsewhere in the market, biopharma is a great place to look for stocks to pack into your portfolio because there’s always an illness that can be treated more effectively in the future than it is being treated today.
Our trade...
The Federal Reserve affirmed its dedication to its battle against inflation during this week’s FOMC meeting minutes release. Amid mounting concerns that the Fed will continue hiking interest rates, many investors are seeking ways to shore up their portfolios.
Investing in dividend-paying stocks...
The past year has produced a performance chasm between value and growth equities, with value recapturing the lead following a strong run for growth in recent years. As interest rates rose rapidly in 2022, with the fed funds rate now around 4.3%, we saw downward pressure on...
Growth stocks got hammered in 2022, but investors want a fresh start in 2023. With certain stocks down more than 75% from their highs, many are searching for diamonds in the rubble.
If you believe in the buy-low, sell-high...